Clinical Report: Assessing Comorbidities in Psoriasis Through TCM Constitution
Overview
This prospective cohort study aims to evaluate the predictive value of Traditional Chinese Medicine (TCM) constitution types and multimodal clinical data for comorbidity risk in psoriasis patients.
Background
Psoriasis is a chronic inflammatory skin disease with a global prevalence of approximately 2%–4%, often accompanied by various systemic comorbidities. The variability in treatment responses among patients complicates management, highlighting the need for effective predictive tools.
Data Highlights
This study will enroll 1000 adults with psoriasis, collecting data on TCM constitution types and clinical indicators over 52 weeks.
Key Findings
The study will assess the relationship between TCM constitution types and comorbidity risk in psoriasis.
It aims to evaluate the effectiveness of systemic therapies based on TCM constitution.
Data collection will include multimodal clinical data and syndrome patterns.
The study protocol has received ethical approval from relevant medical ethics committees.
Results will be disseminated through peer-reviewed journals and public forums.
Clinical Implications
The findings may help in developing personalized treatment strategies for psoriasis by integrating TCM constitution types with modern clinical data. This approach could enhance the understanding of comorbidity risks and treatment responses in psoriasis patients.
Conclusion
This study represents a significant step towards validating TCM constitution theory in the context of psoriasis and its comorbidities, potentially leading to improved patient management.
